This inventor holds 4 USPTO granted patents and 1 EPO patent. Top assignees: Cedarburg Pharmaceuticals, Inc., Other. Active years: 1996-2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 3 
2 out of 834,570 Years Active: 1996-2013
Title: Scot W Weis: Innovator in Aromatase Inhibitors
Introduction
Scot W Weis is a notable inventor based in Milwaukee, WI (US), recognized for his contributions to the field of pharmaceuticals. He holds a total of 4 patents, showcasing his innovative approach to drug development.
Latest Patents
One of his latest patents is titled "Exemestane and its intermediates and methods of making the same." This patent describes a method for preparing an aromatase inhibitor of a specific formula, where various components can be hydrogen, halogen, or C-Calkyl. The process involves reacting a compound with a deprotonating agent and a specific compound to obtain a new compound, which is then reacted with a base to form the desired aromatase inhibitor.
Career Highlights
Throughout his career, Scot has worked with Cedarburg Pharmaceuticals, Inc., where he has contributed significantly to pharmaceutical innovations. His work has focused on developing methods that enhance the efficacy of aromatase inhibitors, which are crucial in treating certain types of cancer.
Collaborations
Scot has collaborated with notable professionals in the field, including John P Maye and Kevin Kunnen. These collaborations have further enriched his research and development efforts.
Conclusion
Scot W Weis stands out as an influential inventor in the pharmaceutical industry, particularly in the development of aromatase inhibitors. His innovative methods and collaborations have made significant contributions to medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile